about
The mechanism of Intralipid®-mediated cardioprotection complex IV inhibition by the active metabolite, palmitoylcarnitine, generates reactive oxygen species and activates reperfusion injury salvage kinasesHigh levels of anti-inflammatory and pro-resolving lipid mediators lipoxins and resolvins and declining docosahexaenoic acid levels in human milk during the first month of lactationLoss of Intralipid®- but not sevoflurane-mediated cardioprotection in early type-2 diabetic hearts of fructose-fed rats: importance of ROS signalingResolvin D1 Polarizes Primary Human Macrophages toward a Proresolution Phenotype through GPR32A dinucleotide deletion in amyloid precursor protein (APP) mRNA associated with sporadic Alzheimer's disease results in efficient secretion of truncated APP isoforms from neuroblastoma cell cultures.Excellent agreement between genetic and hydrogen breath tests for lactase deficiency and the role of extended symptom assessment.Clinical criteria replenish high-sensitive troponin and inflammatory markers in the stratification of patients with suspected acute coronary syndrome.Deoxysphingoid bases as plasma markers in diabetes mellitus.Potential role of the lipoxygenase derived lipid mediators in atherosclerosis: leukotrienes, lipoxins and resolvins.Regulation of the formyl peptide receptor 1 (FPR1) gene in primary human macrophagesPharmacokinetics and pharmacodynamics of cinacalcet in patients with hyperparathyroidism after renal transplantation.The two faces of the 15-lipoxygenase in atherosclerosis.Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.Genetic deletion of p66(Shc) adaptor protein prevents hyperglycemia-induced endothelial dysfunction and oxidative stress.Effects of Steroid Hormones on Sex Differences in Cerebral Perfusion.High density lipoproteins in the intersection of diabetes mellitus, inflammation and cardiovascular disease.Current understanding of the metabolism and biological actions of HDL.TLR9 agonists induced cell death in Burkitt's lymphoma cells is variable and influenced by TLR9 polymorphismModulation of high-density lipoprotein cholesterol metabolism and reverse cholesterol transport.Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension.Early mitochondrial dysfunction in glycolytic muscle, but not oxidative muscle, of the fructose-fed insulin-resistant rat.Serological and DNA-based evaluation of Chlamydia pneumoniae infection in inflammatory bowel disease.Increased T-bet to GATA-3 ratio during acute allograft rejection in the rat lung.Laughing Gas in a Pediatric Emergency Department-Fun for All Participants: Vitamin B12 Status Among Medical Staff Working With Nitrous Oxide.Clinical phenotype, biochemical profile, and treatment in 19 patients with arginase 1 deficiency.Low dose aspirin is associated with plasma chemerin levels and may reduce adipose tissue inflammation.Milder forms of atherogenic dyslipidemia in ovulatory versus anovulatory polycystic ovary syndrome phenotype.Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.Extralymphatic virus sanctuaries as a consequence of potent T-cell activation.Functional polymorphism in ALOX15 results in increased allele-specific transcription in macrophages through binding of the transcription factor SPI1.Diagnostic performance of S100B protein serum measurement in detecting intracranial injury in children with mild head trauma.Gender-Related Differences in Patients Presenting with Suspected Acute Coronary Syndromes: Clinical Presentation, Biomarkers and Diagnosis.Phylogenetic analysis of the apolipoprotein B mRNA-editing region. Evidence for a secondary structure between the mooring sequence and the 3' efficiency element.Characterization of the promoter and the transcriptional regulation of the lipoxin A4 receptor (FPR2/ALX) gene in human monocytes and macrophages.Expression and regulation of 12/15-lipoxygenases in human primary macrophages.Metabolic profiling of hearts exposed to sevoflurane and propofol reveals distinct regulation of fatty acid and glucose oxidation: CD36 and pyruvate dehydrogenase as key regulators in anesthetic-induced fuel shift.HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load.Regulatable liver expression of the rabbit apolipoprotein B mRNA-editing enzyme catalytic polypeptide 1 (APOBEC-1) in mice lacking endogenous APOBEC-1 leads to aberrant hyperediting.Serum creatinine, cystatin C, and beta-trace protein in diagnostic staging and predicting progression of primary nondiabetic chronic kidney disease.Excessive daytime sleepiness in Behçet's disease with diencephalic lesions and hypocretin dysfunction.
P50
Q21132337-F944220B-81ED-4333-A53F-EE639D5EF91FQ21245689-D58488F6-1B89-41AE-B5E0-F4AEFA42DCD6Q27314973-A4BB28AC-8DE1-4583-9B36-19FD3E113933Q28274076-FA9AF818-1905-4886-BF12-E609945A0E2EQ32134036-FB5EBB85-30C1-4B65-92F8-857761C8D676Q33557938-2836CE97-BC2D-4408-8FD8-5C319ED42F63Q33706806-70DE0BE7-D966-417B-B4EA-BBE95045D9AEQ34098049-277FC1B8-8894-49EF-9738-58BAD3F3261DQ34113615-9549B4BA-9367-4E09-BFF7-EC19EA1913DCQ34491175-58884D01-FEB9-44F4-900A-3B5DAED8BBD1Q34589090-B9242BDF-A3D1-4D32-8EED-5E36A5B9AF7EQ34687589-979CE8C7-4CAC-4D0C-AE5A-F6D3D3AB01A8Q35203793-699AD924-1578-4632-86DC-C79C3EB1B573Q35691127-5059E5C3-1F1C-4194-B4E0-2953FA0B748CQ35769325-D1ABBB46-3609-47C5-853E-BF9CDB394431Q35786190-95C2A064-C499-4BB3-8A49-9AC47726329FQ36045056-0CE91793-C85C-4B3D-8523-B03826FBBE78Q36071989-632069C5-10B6-45C3-B133-9C2BE9C3B437Q36441294-E9DBEF46-1AD6-4644-A7D1-629164E9B378Q37198601-738E0A04-D455-462D-B614-54DE3DC45155Q37629051-7CEF56A4-A7A3-43EB-B996-6293A55D51C9Q37861895-1048DF7F-EA12-42C6-B23F-EC480291B88DQ38348100-DC35D8EE-9101-4D38-BF15-073B9232385BQ38546834-ED4AE081-F91E-43D0-9A85-B228405572E5Q38886946-6E58540C-7515-40EA-A9C8-D53D22A8F247Q38989712-691FD1C7-28D2-4821-8E51-CE3B57E6E908Q39978301-8C42F65A-7906-4E0D-8710-69ACE18E51F5Q40012257-B638B2A7-AAEA-4C54-9744-4C590A06CA13Q40056632-601DE7D1-8D32-4CCF-93C4-5A88C9FD230EQ40345415-DE6A1237-0A49-4D80-B0A0-809BB61E236DQ40632668-A50A3941-88BD-4147-89B3-60274F2A9E96Q40638286-F41619EB-5091-488D-8A4F-8BD4CC12EE16Q41704284-3E57FE62-1095-47B3-BE42-267A8EC3D7B3Q42500558-E1C44D77-CD0C-4C6B-BA22-A59822586F86Q42512736-CFBE9D86-8759-4161-83F3-660F50428C3CQ42947498-85199D13-B83E-42FA-8709-EE0A5E428555Q42983978-55A7098D-932C-416F-94D9-3A0E09F87AB6Q43002584-E763B5CB-E099-4808-8E32-7DFB84EB50BEQ43132695-F1E25A8E-1D66-49F5-9984-0E296A084567Q43142521-23BA851D-3276-4893-9508-608182BC423A
P50
description
hulumtues
@sq
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Martin Hersberger
@ast
Martin Hersberger
@en
Martin Hersberger
@es
Martin Hersberger
@fr
Martin Hersberger
@nl
Martin Hersberger
@sl
type
label
Martin Hersberger
@ast
Martin Hersberger
@en
Martin Hersberger
@es
Martin Hersberger
@fr
Martin Hersberger
@nl
Martin Hersberger
@sl
prefLabel
Martin Hersberger
@ast
Martin Hersberger
@en
Martin Hersberger
@es
Martin Hersberger
@fr
Martin Hersberger
@nl
Martin Hersberger
@sl
P106
P21
P31
P3835
martin-hersberger
P496
0000-0002-4472-329X